Manufacturing Advanced Therapies: Clinical Center Operational Considerations for Decentralized Manufacturing
Industry:
Biopharma
Type:
Podcast
Location:
Miami, Florida
This first panel features insights from Carol Houts (CSO, Germfree) and Heather Purvis (Director of Clinical Operations, Title21 Health Solutions), as they discuss the operational intricacies of the recently-announced partnership between Germfree and Title21 Health Solutions. Discover the collaborative efforts of both companies as they integrate innovative manufacturing infrastructure with regenerative medicine-focused software. This partnership aims to streamline the intricate process of advanced therapies production, allowing healthcare professionals to concentrate on delivering patient-centered care. Explore the practical solutions offered by this collaboration, addressing logistical challenges and contributing to the evolution of healthcare manufacturing.
You might also be interested in
Inside Germfree’s Isolator Engineering Process
Why Mobile and Modular Cleanrooms are Changing the Game in Bio-Manufacturing
Smarthood™: Setting a New Standard in IV Compounding
Contact us: Let's unlock your scientific potential together
Complete our contact form and a member of our commercial team will contact you within 24 hours.